Literature DB >> 21116743

Introduction to section on integrative oncology.

Kathleen M Wesa, Barrie R Cassileth.   

Abstract

Mesh:

Year:  2010        PMID: 21116743     DOI: 10.1007/s11864-010-0133-1

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


× No keyword cloud information.
  5 in total

1.  Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.

Authors:  Gary E Deng; Moshe Frenkel; Lorenzo Cohen; Barrie R Cassileth; Donald I Abrams; Jillian L Capodice; Kerry S Courneya; Trish Dryden; Suzanne Hanser; Nagi Kumar; Dan Labriola; Diane W Wardell; Stephen Sagar
Journal:  J Soc Integr Oncol       Date:  2009

2.  Increased telomerase activity and comprehensive lifestyle changes: a pilot study.

Authors:  Dean Ornish; Jue Lin; Jennifer Daubenmier; Gerdi Weidner; Elissa Epel; Colleen Kemp; Mark Jesus M Magbanua; Ruth Marlin; Loren Yglecias; Peter R Carroll; Elizabeth H Blackburn
Journal:  Lancet Oncol       Date:  2008-09-15       Impact factor: 41.316

3.  Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.

Authors:  Joanne Frattaroli; Gerdi Weidner; Ann M Dnistrian; Colleen Kemp; Jennifer J Daubenmier; Ruth O Marlin; Lila Crutchfield; Loren Yglecias; Peter R Carroll; Dean Ornish
Journal:  Urology       Date:  2008-07-07       Impact factor: 2.649

4.  Complementary and alternative medicine use among adults and children: United States, 2007.

Authors:  Patricia M Barnes; Barbara Bloom; Richard L Nahin
Journal:  Natl Health Stat Report       Date:  2008-12-10

5.  Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

Authors:  Dean Ornish; Mark Jesus M Magbanua; Gerdi Weidner; Vivian Weinberg; Colleen Kemp; Christopher Green; Michael D Mattie; Ruth Marlin; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.